NCT05084417 A Prospective, Observational Study of Clinician and Patient-reported Outcomes in Patients With Dermatological Conditions Status ENROLLING_BY_INVITATION Phase N/A
NCT05081557 A Study to Assess Real-World Use, Safety, and Effectiveness of Oral Upadacitinib in Adult and Adolescent (>=12 Years Old) Participants With Atopic Dermatitis Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05062213 A Clinical Trial to Evaluate the Safety and Efficacy of a Moisturizer Body Lotion in Adults of Atopic Dermatitis. Status COMPLETED Phase NA
NCT05059509 Evaluate Efficacy of FB825 in Adults With Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT05048056 Phase 2 Study of Efficacy and Safety of AK120, in Subjects With Moderate-to-Severe Atopic Dermatitis Status TERMINATED Phase PHASE2
NCT05042258 Using Dupilumab to Improve Circadian Function, Sleep and Pruritus in Children With Moderate/Severe Atopic Dermatitis Status RECRUITING Phase PHASE4
NCT05034822 Study of Ruxolitinib Cream in Children With Atopic Dermatitis Status COMPLETED Phase PHASE1
NCT05032859 Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults (DMVT-505-3102) Status COMPLETED Phase PHASE3
NCT05031754 Assessing SleeP IN Infants With Atopic Dermatitis by Longitudinal Evaluation Status UNKNOWN Phase N/A
NCT05029895 A Study to Evaluate Adverse Events and Change in Disease State of Oral Upadacitinib in Adolescent Participants Ages 12 to <18 Years Old Diagnosed With Atopic Dermatitis (AD) Status COMPLETED Phase N/A
NCT05019209 Skin Responses and T Cell Immunology After House Dust Mite Exposure in Sensitized Atopic Dermatitis Patients Status COMPLETED Phase NA
NCT05018806 Proof of Concept Study of Rilzabrutinib in Adult Patients With Moderate-to-severe Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT05016284 Comparison of JW-100 and EUCRISA for the Treatment of Atopic Dermatitis Status WITHDRAWN Phase PHASE3
NCT05014568 Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults Status COMPLETED Phase PHASE3
NCT05006300 Evaluation of the Efficacy of Topialyse Baume barrière on Atopic Dermatis Status WITHDRAWN Phase NA
NCT04992546 Phase 2a Study of the Safety, Tolerability, and Pharmacokinetics of Topically Administered PRN473 (SAR444727) in Patients With Mild to Moderate Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT04984941 Evaluation of the Role of IgE Responses to Der p 1 and Der p 2 in Chinese House Dust Mite-Allergic Patients Status COMPLETED Phase N/A